Results 181 to 190 of about 78,818 (344)

Positron Emission Tomography/Computed Tomography in Ovarian Cancer: Current Status and Future Potential

open access: yesiRADIOLOGY, Volume 3, Issue 5, Page 337-352, October 2025.
The role of PET/CT in the management of ovarian cancer at each disease stage, including primary detection, staging, prognosis evaluation, treatment response assessment and recurrence surveillance, and its future potential in relation to novel non‐FDG radiotracers, PET/MRI, dynamic PET and AI‐based radiomics.
Caiyun Xu   +4 more
wiley   +1 more source

Evaluation of 99mTc-phytate as Radiopharmaceutical

open access: bronze, 1976
Isao Ikeda   +3 more
openalex   +2 more sources

Radiopharmaceutical Production and Quality Control [PDF]

open access: yes, 1975
With the development of shorter-lived, organ-specific radiopharmaceuticals, much of the manufacture and quality control of these products have shifted from commercial manufactures to individual nuclear medicine laboratories.
Hirsch, Jerry I.
core   +1 more source

The Value of [18F]FDG PET/CT for Differentiating Neoplastic From Benign Thrombus

open access: yesiRADIOLOGY, Volume 3, Issue 5, Page 353-361, October 2025.
Schematic overview of vascular thrombus in cancer patients and the diagnostic utility of [18F]FDG PET/CT for differentiating neoplastic from benign thrombus. Left: Illustrative diagram depicting tumor‐induced vascular thrombus formation in malignant tumor patients (created using FigDraw [by figdraw. com] with authorization; IDs: AORTA66266).
Xiaofeng Dou   +8 more
wiley   +1 more source

Sterically chained amino acid-rich water-soluble carbon quantum dots as a robust tumor-targeted drug delivery platform

open access: yesNature Communications
Effective antitumor nanomedicines maximize therapeutic efficacy by prolonging drug circulation time and transporting drugs to target sites. Although numerous nanocarriers have been developed for accurate tumor targeting, their limited water solubility ...
Wenjing Xie   +11 more
doaj   +1 more source

Are we “preparing” radiopharmaceuticals? [PDF]

open access: yesEJNMMI Radiopharmacy and Chemistry, 2016
Marianne Patt, Clemens Decristoforo
openaire   +4 more sources

Estimation the Maximum Tolerance Activity of Blood by a Simple Algorithm Method in Pediatric Differentiated Thyroid Cancer Patients Treated With Empirical Radioactive Iodine Dosing Based on Risk Stratification

open access: yesThe Kaohsiung Journal of Medical Sciences, Volume 41, Issue 10, October 2025.
ABSTRACT After total thyroidectomy for pediatric differentiated thyroid cancer (DTC), the subsequent radioactive iodine (RAI) treatment is a robust therapy, the dosing of which is a major concern. This study was designed to evaluate the “as high as safe administration” (AHASA) principle of RAI treatment in pediatric DTC patients based on the maximum ...
Yu‐Wen Chen   +8 more
wiley   +1 more source

Substantia Nigra Iron Deposition in Lewy Body Disease: A Magnetic Resonance Imaging and Neuropathology Study

open access: yesMovement Disorders, Volume 40, Issue 10, Page 2129-2138, October 2025.
Abstract Objective To compare iron deposition in the substantia nigra (SN) as measured with quantitative susceptibility mapping (QSM) on antemortem magnetic resonance imaging (MRI) between individuals with and without Lewy‐related pathology at autopsy. Methods We performed a retrospective cohort study including 54 participants who underwent autopsy and
Patricia Diaz‐Galvan   +28 more
wiley   +1 more source

Home - About - Disclaimer - Privacy